Dexrazoxane Hydrochloride and Moxetumomab Pasudotox-tdfk
Determining the interaction of Dexrazoxane Hydrochloride and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Hydrochloride-Moxetumomab pasudotox-tdfk Intravenous
- Dexrazoxane Hydrochloride-Moxifloxacin
- Dexrazoxane Hydrochloride-Moxifloxacin (Systemic)
- Dexrazoxane Hydrochloride-Moxifloxacin Hydrochloride
- Dexrazoxane Hydrochloride-Moxifloxacin Injection
- Dexrazoxane Hydrochloride-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Dexrazoxane Intravenous
- Moxetumomab Pasudotox-tdfk-Dextenza Insert
- Moxetumomab Pasudotox-tdfk-Dextenza intraocular
- Moxetumomab Pasudotox-tdfk-Dextran 40
- Moxetumomab Pasudotox-tdfk-Dextran 70 6% in 5% Dextrose high molecular weight
- Moxetumomab Pasudotox-tdfk-Dextran 75